ArticleBMC microbiology2025
Fusarium oxysporum assisted green synthesis of small-sized silver nanoparticles for high antibacterial, and photocatalytic decolorization performances.
Article in BMC microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Green mycosynthesis of small-sized silver nanoparticles (ss-AgNPs) from endophytic Fusarium solani and their multi-target biomedical profiles.Scientific reports · 2026Article
- Mechanistic advances in microbial nanobiotechnology and their applications in sustainable agriculture, environment and biomedicine.Discover nano · 2026Review
- Peltophorum pterocarpum flower mediated synthesis of silver nanoparticles and its catalytic degradation of Acid Blue 113 dye.Scientific reports · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundNovel platforms using nanotechnology-based medicines have exponentially increased in our daily lives. The unique characteristics of metal oxide and noble metals nanoparticles make them suitable for different fields including antimicrobial agents, cosmetics, textiles, wound dressings, and anticancer drug carriers.
methodsThis study focuses on the biosynthesis of small-sized SNPs using exo-metabolites of Fusarium oxysporum via bioprocess optimization using Plackett-Burman (PBD) and central composite designs (CCD) while evaluating their multifaceted bioactivities.
resultsThe successful biofabrication of smaller-sized SNPs with an average particle size of ~ 5 nm was achieved upon the bioprocess optimization. The developed SNPs exhibited significant antibacterial activity against multidrug-resistant bacterial pathogens in a concentration- and time-dependent manner. The minimum inhibitory concentrations (MICs) for SNPs were 0.078 µg/ml (Escherichia coli), 0.156 µg/ml (Pseudomonas aeruginosa), and 1.25 µg/ml (Enterococcus faecalis), while the minimum bactericidal concentrations (MBCs) were correspondingly 0.156 µg/ml, 0.312 µg/l, and 1.25 µg/ml. SNPs-treated cells displayed bacteriostatic and bactericidal effects as revealed by time-kill assay and the ultrastructure changes observed in SEM and TEM analyses. The results marked the potent antioxidant activity of SNPs against DPPH, O
conclusionsThe green synthesis of SNPs by F. oxysporum exometabolites is eco-friendly, and inexpensive, with the production of small-size, and greatly stabilized nanoparticles. This study corroborated that SNPs can be highly promising enough to be applied for antibacterial and anticancer control systems, for ameliorating free radical-related disorders, and as a photocatalyst for wastewater treatment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.